Medplus Health — 360° view

Medplus Health, a company in the Pharmacy Retail industry, reported revenue of ₹2,037 crore and net profit of ₹56 crore for the September 2026 quarter.

Medplus Health (NSE: MEDPLUS) closed at ₹603.95 on 20 Nov 2026, down 22.7% over the past year. Its market capitalisation is ₹7,257 crore and it trades at 34.4 times earnings.

Share price
₹603.95 (20 Nov 2026)
Market cap
₹7,257 Cr (20 Nov 2026)
P/E
34.38 (20 Nov 2026)
Revenue
₹2,037 Cr (September 2026 quarter)
Net profit
₹56 Cr (September 2026 quarter)
ROCE
12.6% (FY26)
ROE
11.7% (FY26)
Book value
₹172 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹1,022.20 / ₹565.60 (20 Nov 2026)
1-year return
-22.7% (to 20 Nov 2026)
Sector
Consumer Discretionary
Industry
Pharmacy Retail
Symbol
NSE: MEDPLUS

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.